Genesis Biotechnology Group

Genesis Biotechnology Group, established in 2017, is a prominent entity within the Business Services sector, with a specialized focus on biotechnology. The company's core mission involves providing comprehensive corporate research services, including the implementation and delivery of fundamental scientific products. Key offerings encompass advanced Diagnostic Essays and critical support for drug discovery programs. Genesis Biotechnology Group actively engages the B2B market, delivering vital solutions designed to accelerate scientific progress and innovation across the industry.

The organization demonstrates a robust operational scale, managing a network of five distinct locations to support its diverse research and development activities. Genesis Biotechnology Group's workforce comprises between 500 and 1,000 employees, reflecting a significant investment in human capital and operational capacity. Financially, the company reports substantial revenue of $359.3 million, a testament to its established market presence and economic impact within the biotechnology and broader business services landscape. This considerable scale enables the execution of complex, long-term research projects.

Operating within a dynamic and competitive market, Genesis Biotechnology Group contends with notable industry players such as Adaptive Biotechnologies and Crown Bioscience. The company differentiates itself through its dedicated focus on specialized research areas, particularly in drug discovery and the development of sophisticated diagnostic tools. These strategic priorities position Genesis Biotechnology Group as a significant contributor to scientific advancement. For a deeper understanding of the human element driving these achievements, interested parties can Meet Genesis Biotechnology Group's team, exploring the collective expertise and leadership that underpins the company's ongoing success and strategic direction.